Human nuclear RNAi-defective 2 (NRDE2) is an essential RNA splicing factor

por Jiao, Alan L., Perales, Roberto, Umbreit, Neil T., Haswell, Jeffrey R., Piper, Mary E., Adams, Brian D., Pellman, David, Kennedy, Scott, Slack, Frank J.
Publicado 2019

The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers

por Alver, Burak H., Kim, Kimberly H., Lu, Ping, Wang, Xiaofeng, Manchester, Haley E., Wang, Weishan, Haswell, Jeffrey R., Park, Peter J., Roberts, Charles W. M.
Publicado 2017

Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency

por Haswell, Jeffrey R., Mattioli, Kaia, Gerhardinger, Chiara, Maass, Philipp G., Foster, Daniel J., Peinado, Paola, Wang, Xiaofeng, Medina, Pedro P., Rinn, John L., Slack, Frank J.
Publicado 2021

ARID1B is a specific vulnerability in ARID1A-mutant cancers

por Helming, Katherine C., Wang, Xiaofeng, Wilson, Boris G., Vazquez, Francisca, Haswell, Jeffrey R., Manchester, Haley E., Kim, Youngha, Kryukov, Gregory V., Ghandi, Mahmoud, Aguirre, Andrew J., Jagani, Zainab, Wang, Zhong, Garraway, Levi A., Hahn, William C., Roberts, Charles W. M.
Publicado 2014

BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors

por Wang, Xiaofeng, Wang, Su, Troisi, Emma C., Howard, Thomas P., Haswell, Jeffrey R., Wolf, Bennett K., Hawk, William H., Ramos, Pilar, Oberlick, Elaine M., Tzvetkov, Evgeni P., Ross, Aaron, Vazquez, Francisca, Hahn, William C., Park, Peter J., Roberts, Charles W. M.
Publicado 2019

Author Correction: BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors

por Wang, Xiaofeng, Wang, Su, Troisi, Emma C., Howard, Thomas P., Haswell, Jeffrey R., Wolf, Bennett K., Hawk, William H., Ramos, Pilar, Oberlick, Elaine M., Tzvetkov, Evgeni P., Ross, Aaron, Vazquez, Francisca, Hahn, William C., Park, Peter J., Roberts, Charles W. M.
Publicado 2019

SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation

por Wang, Xiaofeng, Lee, Ryan S., Alver, Burak H., Haswell, Jeffrey R., Wang, Su, Mieczkowski, Jakub, Drier, Yotam, Gillespie, Shawn M., Archer, Tenley C., Wu, Jennifer N., Tzvetkov, Evgeni P., Troisi, Emma C., Pomeroy, Scott L., Biegel, Jaclyn A., Tolstorukov, Michael Y., Bernstein, Bradley E., Park, Peter J., Roberts, Charles W. M.
Publicado 2016

Engineered Cas12i2 is a versatile high-efficiency platform for therapeutic genome editing

por McGaw, Colin, Garrity, Anthony J., Munoz, Gabrielle Z., Haswell, Jeffrey R., Sengupta, Sejuti, Keston-Smith, Elise, Hunnewell, Pratyusha, Ornstein, Alexa, Bose, Mishti, Wessells, Quinton, Jakimo, Noah, Yan, Paul, Zhang, Huaibin, Alfonse, Lauren E., Ziblat, Roy, Carte, Jason M., Lu, Wei-Cheng, Cerchione, Derek, Hilbert, Brendan, Sothiselvam, Shanmugapriya, Yan, Winston X., Cheng, David R., Scott, David A., DiTommaso, Tia, Chong, Shaorong
Publicado 2022